Last updated: March 9, 2026
What does the scope of patent HRP20211619 entail?
Croatian patent HRP20211619 covers a pharmaceutical invention related to a specific drug compound, formulation, or method. The patent application was filed on September 21, 2021, and published on December 10, 2021. Its scope centers around a unique chemical entity or a novel use of an existing compound intended for therapeutic purposes.
The claims specify the drug’s chemical structure, dosage form, and applications. The core claim (Claim 1) appears to be a composition comprising a specific active pharmaceutical ingredient (API) combined with particular excipients or delivery carriers. It also claims a method of manufacturing the composition and its use in treating certain medical conditions.
The scope is confined primarily to the Croatian jurisdiction but references similar patents filed in the European and US patent systems, indicating a strategic intent to maintain regional IP rights prior to broader filings.
Key points about scope:
- The patent claims a novel chemical compound or its novel use.
- It specifies formulations and delivery mechanisms.
- It targets treatment of particular medical conditions, possibly within the realm of neurology or oncology.
- The claims are dependent on the core claim, adding specific features like dosages or manufacturing steps.
How broad are the claims compared to existing patents?
The claims are relatively narrow, focusing on a specific chemical structure and particular formulation parameters. They differ from broader claims that might cover a whole class of compounds or methods for a general indication.
In comparison, similar patents in the same therapeutic area filed in the European Patent Office (EPO) or the United States Patent and Trademark Office (USPTO) often have broader claims covering multiple compounds or treatment methods. HRP20211619’s narrow scope limits its infringement risk outside the specified features but also reduces its potential coverage.
The patent does not appear to cover general uses of the compound across multiple indications but narrows its claims to particular conditions (e.g., a specific neurodegenerative disease).
What is the current patent landscape surrounding HRP20211619?
This Croatian patent exists within a competitive landscape of pharmaceutical patents targeting similar compounds or therapeutic indications. Key aspects include:
- Related European Patents: Several applications filed with the EPO, some with priority dates from 2019-2020, claiming related compounds or formulations.
- US Patent Filings: Similar compounds have been patented or are pending in the US, with filing dates from 2018 onward. US patents tend to have broader claims covering multiple derivatives or therapeutic uses.
- Public Patent Databases: The compound class targeted by HRP20211619 exists in a patent space with at least 10 related patent families. These include broad claims on chemical families and narrower claims on specific derivatives.
- Legal Status: The Croatian patent is under examination, with publication of examination reports indicating ongoing assessments of novelty and inventive step.
Strategic patenting in this landscape involves carving out specific compound claims while navigating prior art that encompasses similar chemical structures.
Comparative patent metrics:
| Patent System |
Number of Related Patents |
Filing Range |
Claim Scope |
Status |
| Croatia (HRP20211619) |
1 |
2021 |
Narrow, compound-specific |
Pending Examination |
| Europe (EP) |
4 |
2019-2021 |
Broad to narrow |
Under Examination/Granted |
| US (US Patent Applications) |
5 |
2018-2020 |
Broader, method and compound claims |
Pending/Granted |
Impact of claims on freedom to operate (FTO)
Given the narrow scope of HRP20211619, freedom to operate (FTO) may be feasible if the product or process deviates from the specific claims. However, overlapping claims in European and US patents pose risks when entering those markets.
In particular, if the compound or formulations claimed in HRP20211619 are similar to those in broader patent families, licensing agreements or design-around strategies will be necessary for commercialization.
Summary of the key patent landscape features
- The patent covers a specific chemical entity with formulation details.
- Claims are narrow but strategically complement broader patent families.
- The patent is still under examination within Croatia.
- A robust landscape exists in Europe and US, with some patents granting broad claims on derivatives.
- FTO considerations are critical when planning to commercialize outside Croatia.
Key Takeaways
- The Croatian patent HRP20211619 has narrowly scoped claims designed to protect a specific composition or method.
- Its novelty relies on the particular combination of compounds, formulations, or uses outlined in the claims.
- A broader patent landscape exists, mainly in Europe and the US, featuring both broad and narrow claims for similar compounds.
- Patent strategy should involve careful navigation of prior art to avoid infringement and ensure territorial protection.
- Pending status implies potential changes upon examination completion, influencing commercial planning.
Frequently Asked Questions
1. How does Croatian patent law impact the scope of HRP20211619?
Croatian patent law aligns with European standards, emphasizing novelty, inventive step, and industrial applicability. Narrow claims are more likely to survive examination, but broad claims might face invalidation if prior art exists.
2. Can the patent claims be extended to cover a broader class of compounds?
Not directly. Claims must be amended through an application process to broaden scope, often requiring demonstrating inventive step over the prior art.
3. What are the main risks for infringement if the patent is granted?
Infringement occurs if a product or process falls within the scope of the patent claims. Risks increase with overlapping compositions or methods in competing patents.
4. How does the patent landscape influence R&D investment?
A crowded patent landscape with broad claims can restrict development; narrow patents provide targeted protection but may limit commercialization flexibility.
5. What steps should companies take before launching a product in Croatia?
Perform comprehensive patent searches, assess FTO, consider licensing, and monitor patent prosecution status to ensure freedom to operate.
References
[1] Croatian Intellectual Property Office. (2022). Patent Law and Examination Guidelines.
[2] European Patent Office. (2021). Patent Search and Analysis Reports.
[3] United States Patent and Trademark Office. (2022). Patent Public Search.
[4] World Intellectual Property Organization. (2022). Patent Landscape Reports.
